Tatanggalin na ang ‘red tape’ sa pag-apruba ng bagong gamot at maglulunsad ng mga pamamaraan si Food and Drug Administration (FDA) Director General Dr. Samuel Zacate para suportahan ang kagustuhan ni Pangulong Ferdinand Marcos, Jr. na magkaroon ng abot-kayang presyo ng gamot sa mga Pilipino.
Tiniyak din ni Zacate na magkakaroon ng parehas na kompetisyon sa pharmaceutical sector.
Ang pahayag ay ginawa ni Zacate sa kanyang pagsasalita sa
General Membership Meeting ng Philippine Chamber of the Pharmaceutical Industry, Inc. (PCPI)
“With regard to the FDA, they have stringent requirements and internal processes, but now I have the power to streamline the internal processes, mostly on payments, assessments, and rigid (regulatory) conditions. I will do it,”ayon kay Zacate.
Inihalimbawa pa ni Zacate,ang importation process na gagawin niyan episyente.
Ayon kay Zacate, na ini-appoint ni Marcos magpapatupad ng overhaul ang ahensiya para maging isang world-class regulatory body.
“The long culture of the FDA being on the safe side and being inside the box is long gone because I’m here now,” ani Zacate.
“I cannot let the President fail. So now, I am telling you, I am a man of innovation, I don’t want to be inside the box. I am not keen on the idea that we cannot do something (to a problem) because everything, especially with science, is possible,” dagdag pa ni Zacate.
Nabatid na ang FDA ay may mandato na tiyakin ang kaligtasan,kahusayan at kalidad ng health productsat naging mahalaga ang papel nito sa naganap na global health emergencies gaya ng Covid-19 at monkeypox na nanatiling banta sa ating healthcare system. (Carl Angelo)
